Regulations.gov document
Hospira, Inc., et al.; Withdrawal of Approval of 21 Abbreviated New Drug Applications
Notice · FDA-2022-N-0766 · posted May 20, 2022
Key facts
| Document ID | FDA-2022-N-0766-0001 |
|---|---|
| Title | Hospira, Inc., et al.; Withdrawal of Approval of 21 Abbreviated New Drug Applications |
| Document type | Notice |
| Subtype | Withdrawal |
| Agency | FDA |
| Docket | FDA-2022-N-0766 |
| Posted | May 20, 2022 |
| Federal Register citation | 87 FR 30962 |
| FR document number | 2022-10924 |
| Comment period opens | May 20, 2022 |
| Effective date | May 20, 2022 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: